Oracle Investment Management Inc Top Holdings and 13F Report (2025) About Oracle Investment Management IncInvestment ActivityOracle Investment Management Inc has $198.21 million in total holdings as of March 31, 2025.Oracle Investment Management Inc owns shares of 17 different stocks, but just 5 companies or ETFs make up 80% of its holdings.Approximately 28.09% of the portfolio was purchased this quarter.About 19.62% of the portfolio was sold this quarter.This quarter, Oracle Investment Management Inc has purchased 19 new stocks and bought additional shares in 4 stocks.Oracle Investment Management Inc sold shares of 4 stocks and completely divested from 7 stocks this quarter.Largest Holdings GeneDx $85,903,976SpringWorks Therapeutics $23,448,520SPDR SER TR $22,708,000Biohaven $16,009,318Ardelyx $11,805,791 Largest New Holdings this Quarter 78464A900 - SPDR SER TR $22,708,000 Holding92686J906 - VIKING THERAPEUTICS INC $8,131,305 Holding87918A105 - Teladoc Health $4,504,564 Holding70614W900 - PELOTON INTERACTIVE INC $3,160,000 Holding75629V104 - Recursion Pharmaceuticals $634,800 Holding Largest Purchases this Quarter SPDR SER TR 280,000 shares (about $22.71M)SpringWorks Therapeutics 276,578 shares (about $12.21M)VIKING THERAPEUTICS INC 336,700 shares (about $8.13M)Teladoc Health 565,900 shares (about $4.50M)PELOTON INTERACTIVE INC 500,000 shares (about $3.16M) Largest Sales this Quarter GeneDx 53,514 shares (about $4.74M)Biohaven 185,825 shares (about $4.47M)TELADOC HEALTH INC 153,400 shares (about $1.22M)BIOHAVEN LTD 38,100 shares (about $915.92K) Sector Allocation Over TimeMap of 500 Largest Holdings ofOracle Investment Management Inc Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorWGSGeneDx$85,903,976$4,739,467 ▼-5.2%969,95443.3%MedicalSWTXSpringWorks Therapeutics$23,448,520$12,205,387 ▲108.6%531,35111.8%MedicalSPDR SER TR$22,708,000$22,708,000 ▲New Holding280,00011.5%CALLBHVNBiohaven$16,009,318$4,467,233 ▼-21.8%665,9458.1%MedicalARDXArdelyx$11,805,791$1,546,684 ▲15.1%2,404,4386.0%MedicalVIKING THERAPEUTICS INC$8,131,305$8,131,305 ▲New Holding336,7004.1%CALLARDELYX INC$5,565,485$2,694,608 ▲93.9%1,133,5002.8%CALLTDOCTeladoc Health$4,504,564$4,504,564 ▲New Holding565,9002.3%MedicalQDELQuidelOrtho$4,136,6360.0%118,2912.1%MedicalBIOHAVEN LTD$3,892,076$915,924 ▼-19.1%161,9002.0%CALLPELOTON INTERACTIVE INC$3,160,000$3,160,000 ▲New Holding500,0001.6%CALLFORAForian$2,732,2140.0%1,366,1071.4%MedicalPALANTIR TECHNOLOGIES INC$2,489,800$84,400 ▲3.5%29,5001.3%CL ACAVACAVA Group$1,607,2260.0%18,6000.8%Retail/WholesaleTELADOC HEALTH INC$1,148,628$1,221,064 ▼-51.5%144,3000.6%CALLRXRXRecursion Pharmaceuticals$634,800$634,800 ▲New Holding120,0000.3%MedicalBIIBBiogen$330,0580.0%2,4120.2%MedicalSELECT SECTOR SPDR TR$0$15,820,550 ▼-100.0%00.0%PUTBCRXBioCryst Pharmaceuticals$0$4,027,396 ▼-100.0%00.0%MedicalNOVAVAX INC$0$3,746,640 ▼-100.0%00.0%CALLSPRINGWORKS THERAPEUTICS INC$0$2,016,054 ▼-100.0%00.0%CALLPHATPhathom Pharmaceuticals$0$1,177,920 ▼-100.0%00.0%MedicalPACBPacific Biosciences of California$0$511,738 ▼-100.0%00.0%MedicalEYPTEyePoint Pharmaceuticals$0$242,125 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
